Robert W. Postma's most recent trade in Alaunos Therapeutics Inc was a trade of 6,400 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on July 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 6,400 | 6,400 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 4,050 | 33,133 (0%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Grant, award, or other acquisition of securities at price $ 2.92 per share. | 24 Jun 2025 | 20,804 | 29,083 (0%) | 0% | 2.9 | 60,748 | Common Stock |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jun 2025 | 600 | 600 | - | - | Series A-2 Convertible Preferred Stock | |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 24 Jun 2025 | 500 | 500 | - | - | Series A-1 Convertible Preferred Stock | |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Grant, award, or other acquisition of securities at price $ 2.92 per share. | 11 Apr 2025 | 20,804 | 29,083 (0%) | 0% | 2.9 | 60,748 | Common Stock |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Apr 2025 | 500 | 500 | - | - | Series A-1 Convertible Preferred Stock | |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 12,800 | 12,800 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Purchase of securities on an exchange or from another person at price $ 0.65 per share. | 29 Nov 2022 | 750,000 | 5,000,000 (2%) | 0% | 0.7 | 487,500 | Common Stock |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 1,241,870 (0%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 1,241,870 (0%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Purchase of securities on an exchange or from another person at price $ 1.73 per share. | 02 Sep 2021 | 54,492 | 4,250,000 (1%) | 0% | 1.7 | 94,271 | Common Stock |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Purchase of securities on an exchange or from another person at price $ 1.73 per share. | 02 Sep 2021 | 20,508 | 1,201,870 (0%) | 0% | 1.7 | 35,479 | Common Stock |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 18,750 | 18,750 | - | - | Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Robert W. Postma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 2,500 | 1,181,362 (0%) | 0% | 0 | Common Stock |